Meanwhile, we determined that BLCA patients with higher FDPS expression in both the GSE13507 cohort (Fig. 2d) and the GSE32548 cohort (Supplementary Fig. 2c) had poorer overall survival. The gene discussed is FDPS; the disease is bladder transitional cell carcinoma.